Terms: = Breast cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
57 results:
1. TBACkp: HER2 expression status classification network focusing on intrinsic subenvironmental characteristics of breast cancer liver metastases.
Yang K; Song J; Liu M; Xue L; Liu S; Yin X; Liu K
Comput Biol Med; 2024 Mar; 170():108002. PubMed ID: 38277921
[TBL] [Abstract] [Full Text] [Related]
2. Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis.
Martins-Branco D; Nader-Marta G; Molinelli C; Ameye L; Paesmans M; Ignatiadis M; Aftimos P; Salgado R; de Azambuja E
Eur J Cancer; 2023 Nov; 194():113358. PubMed ID: 37857118
[TBL] [Abstract] [Full Text] [Related]
3. Effects of occupational therapy on quality of life in breast cancer patients: A systematic review and meta-analysis.
He K; Jiang J; Chen M; Wang T; Huang X; Zhu R; Zhang Z; Chen J; Zhao L
Medicine (Baltimore); 2023 Aug; 102(31):e34484. PubMed ID: 37543817
[TBL] [Abstract] [Full Text] [Related]
4. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
5. The Effectiveness and Safety of Stereotactic Body Radiation Therapy (SBRT) in the treatment of Oligoprogressive breast cancer: A Systematic Review.
Yan B; Ramadan S; Jerzak KJ; Louie AV; Donovan E
Curr Oncol; 2023 Jul; 30(7):6976-6985. PubMed ID: 37504365
[TBL] [Abstract] [Full Text] [Related]
6. Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer.
Rodríguez-Gonzalez A; Carmona-Bayonas A; Hernandez San Gil R; Cruz-Castellanos P; Antoñanzas-Basa M; Lorente-Estelles D; Corral MJ; González-Moya M; Castillo-Trujillo OA; Esteban E; Jiménez-Fonseca P; Calderon C
Clin Transl Oncol; 2023 Dec; 25(12):3492-3500. PubMed ID: 37247131
[TBL] [Abstract] [Full Text] [Related]
7. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
[TBL] [Abstract] [Full Text] [Related]
8. Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer.
Lluch-Gómez J; Núñez-Álvarez V; de la Torre-Hita C; Bernal-Gómez M; Campini-Bermejo A; Perdomo-Zaldívar E; Rodríguez-Pérez L; Calvete-Candenas J; Martínez-Bautista MJ; Benítez-Rodríguez E; Baena-Cañada JM
Sci Rep; 2023 May; 13(1):7168. PubMed ID: 37137963
[TBL] [Abstract] [Full Text] [Related]
9. Association of Adherence to Endocrine Therapy Among Patients With breast cancer and Potential Drug-Drug Interactions.
Rassy E; Bardet A; Bougacha O; Gantzer L; Lekens B; Delaloge S; André F; Michiels S; Pistilli B
JAMA Netw Open; 2022 Dec; 5(12):e2244849. PubMed ID: 36459136
[TBL] [Abstract] [Full Text] [Related]
10. Nab-paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative breast cancer: A Phase II Study.
Liu Y; Fan L; Wang ZH; Shao ZM
Oncologist; 2023 Jan; 28(1):86-e76. PubMed ID: 36426808
[TBL] [Abstract] [Full Text] [Related]
11. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
[TBL] [Abstract] [Full Text] [Related]
12. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy of fulvestrant in treating postmenopausal patients with estrogen receptor-positive metastatic breast cancer and prognostic analysis.
Li T; Jiao L
J BUON; 2021; 26(1):189-195. PubMed ID: 33721451
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic features of single bone metastasis in breast cancer.
Karatas M; Zengel B; Durusoy R; Tasli F; Adibelli Z; Simsek C; Uslu A
Medicine (Baltimore); 2021 Jan; 100(1):e24164. PubMed ID: 33429799
[TBL] [Abstract] [Full Text] [Related]
15. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer.
Ko NY; Qureshi MM; Oladeru OT; Cassidy MR; Oshry L; Truong MT; Hirsch AE
Breast Cancer Res Treat; 2020 Dec; 184(3):849-859. PubMed ID: 32888137
[TBL] [Abstract] [Full Text] [Related]
16. Assessing Perceived Discrimination as Reported by Black and White Women Diagnosed with breast cancer.
Sutton AL; Hagiwara N; Perera RA; Sheppard VB
J Racial Ethn Health Disparities; 2021 Jun; 8(3):589-595. PubMed ID: 32808196
[TBL] [Abstract] [Full Text] [Related]
17. Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic breast cancer.
Ratosa I; Orazem M; Scoccimarro E; Steinacher M; Dominici L; Aquilano M; Cerbai C; Desideri I; Ribnikar D; Marinko T; Livi L; Meattini I
Clin Breast Cancer; 2020 Dec; 20(6):495-502. PubMed ID: 32622736
[TBL] [Abstract] [Full Text] [Related]
18. Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer.
Tan H; Wu Y; Bao F; Zhou J; Wan J; Tian J; Lin Y; Wang M
Br J Radiol; 2020 Jul; 93(1111):20191019. PubMed ID: 32401540
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy of texture analysis in determining the gene amplification status of HER2 2+ for invasive ductal carcinoma cases.
Zheng X; Yin J
Minerva Med; 2023 Dec; 114(6):832-838. PubMed ID: 32239879
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of Call-Back Rates between Digital Mammography and Digital breast Tomosynthesis.
Scott AM; Lashley MG; Drury NB; Dale PS
Am Surg; 2019 Aug; 85(8):855-857. PubMed ID: 32051067
[TBL] [Abstract] [Full Text] [Related]
[Next]
